Imagine knowing which card to play

Born from the discovery of powerful genetic markers that influence a person’s response to antipsychotic medications, SureGene provides insights critical to improving antipsychotic and behavioral health treatment decisions.

Insights for antipsychotics you’ve never had until now

SureGene is a powerful method for improving response rates to antipsychotic drugs and reducing hospitalizations, adverse events, and treatment costs. Our antipsychotic efficacy markers have effect sizes nearly twice the size of the most effective drug on the market.1

Learn how SureGene informed treatment improves response rates

Clinical utility.
Delivering on the promise of personalized medicine.

SureGene informed antipsychotic treatment has achieved clinically meaningful outcomes, through endpoints directly measured per genetic targets, SULT4A1 and GLP1R, in clinical trials:

Testing two high-risk patients prevents one hospitalization.*

Finally. Direct cost-savings derived from your laboratory spend. No other biomarker has shown an effect on predicting hospitalizations in comparable analyses. In the transition to value-based care, considering what portion of costs are because the right drug wasn’t prescribed is essential.

SureGene informed treatment is a solution to substantially reduce costs.

Bring personalized medicine to life

Finally, a tool to support safe and effective medication decisions for each of your patients.SureGene is indicated for patients eligible for antipsychotic medications at the following key decision points:

Initial Medication Selection.

For drug-naïve patients or patients who are not currently on medication

Medication Change.

Poor efficacy, tolerability, or patient satisfaction with existing medications

Severe Treatment Failure.

Exacerbations of psychosis, especially those that lead to hospitalization

Learn about SureGene in clinical practice

We research with a passion

“Our lab has a mission to discover, develop, and validate genetic tests that deliver exceptional utility to address the most challenging clinical issues of our time.”– Dr. Heather Fehling, Ph.D., CLSp(MB), TS(MD), HCLD/CC(ABB), Managing Director of Personalized Medicine /Laboratory Director

Learn about our research & publications

A look within. More about SureGene.

Upcoming Events

  • Event Name

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur finibus elit vel enim por, placer

    Learn more
  • Event Name

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur finibus elit vel enim por, placer

    Learn more
View all events

Recent News and Blogs

blog title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur finibus porat. Lorem ipsum dolor sit amet, conse curabitur finibu.Lorem ipsum dolor

Read more

Blog Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur finibus elit vel enim por, placerat.adipiscing elit. Curabitur finibu.Lorem ipsum d

Read more
Sign up to receive updates from our blog